0001104659-23-071187.txt : 20230614 0001104659-23-071187.hdr.sgml : 20230614 20230614160738 ACCESSION NUMBER: 0001104659-23-071187 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230609 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 231014164 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 8-K 1 tm2318622d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 14, 2023 (June 9, 2023)

REGENERON PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

New York

(State or other jurisdiction of incorporation)

000-19034		13-3444607
(Commission File Number)		(I.R.S. Employer Identification No.)

777 Old Saw Mill River Road, Tarrytown, New York		10591-6707
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (914) 847-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock – par value $0.001 per share	REGN	NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.03.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 9, 2023, the Board of Directors (the “Board”) of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”), based upon the recommendation of the Corporate Governance and Compliance Committee of the Board, approved an amendment (the “Amendment”) to Regeneron’s Amended and Restated By-Laws required in connection with the implementation of the previously adopted Board leadership succession plan, as disclosed in the Company’s Current Report on Form 8-K filed April 17, 2023 and the Company’s definitive proxy statement on Schedule 14A (under “Board Governance—Board Leadership Structure—Expected Future Board Leadership Structure”) filed April 21, 2023 (the “Proxy Statement”). The Amendment provides that the Board from time to time may elect two persons to serve as Co-Chairs of the Board and that, if there are Co-Chairs, either Co-Chair may exercise the full powers and authorities of the office.

The foregoing summary of the Amendment is qualified in its entirety by the full text of the Amendment, which is attached as Exhibit 3.2 hereto and is incorporated herein by reference.

Item 5.07.

Submission of Matters to a Vote of Security Holders.

At the 2023 Annual Meeting of Shareholders of the Company held on June 9, 2023, Regeneron’s shareholders voted on the matters set forth below.

Proposal 1 – Election of Directors

The following nominees for Class II directors were elected to serve until the 2026 Annual Meeting of Shareholders and until their successors are duly elected and qualified based upon the following votes:

Nominee		For				Against				Abstain				Broker Non-Votes
Joseph L. Goldstein, M.D.			78,930,855				33,390,357				196,082				4,209,777
Christine A. Poon			84,515,116				27,751,062				251,116				4,209,777
Craig B. Thompson, M.D.			111,784,253				644,879				88,162				4,209,777
Huda Y. Zoghbi, M.D.			108,341,947				4,126,763				48,584				4,209,777

Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm

The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, was approved based upon the following votes:

For:			112,392,480
Against:			4,290,618
Abstain:			43,973

Proposal 3 – Advisory Vote on Executive Compensation

The resolution to approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement was approved based on the following votes:

For:			97,786,842
Against:			14,490,406
Abstain:			240,046
Broker Non-Votes:			4,209,777

Proposal 4 – Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation

One year was selected by a majority of the votes cast on the advisory proposal on the frequency of future advisory votes on executive compensation based upon the following votes:

One Year:			111,204,155
Two Years:			56,571
Three Years:			1,192,972
Abstain:			63,596
Broker Non-Votes:			4,209,777

Proposal 5 – Non-binding Shareholder Proposal Requesting Report on a Process by which Access to Medicine is Considered in Matters Related to Protecting Intellectual Property

The non-binding shareholder proposal requesting report on a process by which access to medicine is considered in matters related to protecting intellectual property was not approved based upon the following votes:

For:			10,554,422
Against:			101,359,081
Abstain:			603,791
Broker Non-Votes:			4,209,777

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description

3.2		Amendment to the Amended and Restated By-Laws effective June 9, 2023.

104		Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	REGENERON PHARMACEUTICALS, INC.

	/s/ Joseph J. LaRosa
	Joseph J. LaRosa
	Executive Vice President, General Counsel and Secretary

Date: June 14, 2023

EX-3.2 2 tm2318622d1_ex3-2.htm EXHIBIT 3.2

Exhibit 3.2

AMENDMENT TO THE BY-LAWS

OF REGENERON PHARMACEUTICALS, INC.

This Amendment (this “Amendment”) to the Amended and Restated By-Laws of Regeneron Pharmaceuticals, Inc., as amended through December 16, 2016 and currently in effect (the “By-Laws”), hereby amends the By-Laws as follows:

1.

Section 7 of Article II of the By-Laws is hereby amended and restated in its entirety as follows:

Section 7. Chairman of the Board. The Board of Directors from time to time may elect a Chairman of the Board. The Chairman of the Board, if one is elected, shall preside at all meetings of the Board of Directors and of the shareholders, and he shall have and perform such other duties as from time to time may be assigned to him by the Board of Directors. The Board of Directors from time to time may also elect two persons to serve as Co-Chairs of the Board (each, a “Co-Chair”). Any reference to the Chairman in these By-Laws shall be deemed to mean, if there are Co-Chairs, either Co-Chair, each of whom may exercise the full powers and authorities of the office.

2.

This Amendment is effective as of June 9, 2023.

3.

As amended by this Amendment, the By-Laws shall remain in full force and effect.

	REGENERON PHARMACEUTICALS, INC.

	By:	/s/ Joseph J. LaRosa
		Name:	Joseph J. LaRosa
		Title:	Executive Vice President, General Counsel and Secretary

EX-101.SCH 3 regn-20230609.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 regn-20230609_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 regn-20230609_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Jun. 09, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jun. 09, 2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-19034
Entity Registrant Name	REGENERON PHARMACEUTICALS, INC.
Entity Central Index Key	0000872589
Entity Tax Identification Number	13-3444607
Entity Incorporation, State or Country Code	NY
Entity Address, Address Line One	777 Old Saw Mill River Road
Entity Address, City or Town	Tarrytown
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10591-6707
City Area Code	914
Local Phone Number	847-7000
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock – par value $0.001 per share
Trading Symbol	REGN
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 7 tm2318622d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000872589 2023-06-09 2023-06-09 iso4217:USD shares iso4217:USD shares 0000872589 false --12-31 8-K 2023-06-09 REGENERON PHARMACEUTICALS, INC. NY 000-19034 13-3444607 777 Old Saw Mill River Road Tarrytown NY 10591-6707 914 847-7000 false false false false Common Stock – par value $0.001 per share REGN NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://regeneron.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2318622d1_8k.htm regn-20230609.xsd regn-20230609_lab.xml regn-20230609_pre.xml tm2318622d1_ex3-2.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2318622d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "tm2318622d1_8k.htm" ] }, "labelLink": { "local": [ "regn-20230609_lab.xml" ] }, "presentationLink": { "local": [ "regn-20230609_pre.xml" ] }, "schema": { "local": [ "regn-20230609.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "regn", "nsuri": "http://regeneron.com/20230609", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2318622d1_8k.htm", "contextRef": "From2023-06-09to2023-06-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://regeneron.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2318622d1_8k.htm", "contextRef": "From2023-06-09to2023-06-09", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://regeneron.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001104659-23-071187-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-071187-xbrl.zip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end